20 March 2023

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

20 March 2023 | n=50

  1. Mital S, Kelly D, Hughes C, Nosyk B, et al.
    Estimated cost-effectiveness of point-of-care testing in community pharmacies versus self-testing and standard laboratory testing for HIV.
    AIDS 2023.

  2. Bonacina S, Niemczak C, Lichtenstein JD, Magohe A, et al.
    Pre-literacy assessment in children living with HIV in Tanzania: comparison to results from children living without HIV in Tanzania and the US.
    AIDS 2023.

  3. Guerville F, Vialemaringe M, Cognet C, Duffau P, et al.
    Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis.
    AIDS 2023.

  4. Temu TM, Polyak SJ, Wanjalla CN, Mandela NA, et al.
    Latent tuberculosis is associated with heightened levels of pro-and anti-inflammatory cytokines among Kenyan men and women living with HIV on long-term antiretroviral therapy.
    AIDS 2023.

  5. Mccluskey SM, Govender K, Adamson J, Gandhi M, et al.
    Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure.
    AIDS 2023.

  6. De Castro N, Chazallon C, Brites C, Messou E, et al.
    Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high-TB burden countries.
    AIDS 2023.

  7. Krishnan A, Sims OT, Surapaneni PK, Woreta TA, et al.
    Risk of Adverse cardiovascular outcomes among persons living with HIV and nonalcoholic fatty liver disease: a multicenter matched cohort study.
    AIDS 2023.

  8. Davies CR, Vaida F, Otwombe K, Cotton MF, et al.
    Pulse wave velocity in early-treated children living with perinatal HIV infection is similar to uninfected children: a longitudinal study.
    AIDS 2023.

  9. Shen M, Xiao Y, Rong L, Zhuang G, et al.
    The impact of attrition on the transmission of HIV and drug resistance: A mathematical modelling study.
    AIDS 2023.

  10. Taramasso L, Squillace N, Ricci E, Menzaghi B, et al.
    Incident diabetes in course of antiretroviral therapy.
    AIDS 2023.

  11. Di Sandro S, Catellani B, Guidetti C, Magistri P, et al.
    Successful living donor liver transplantation from an HIV and HCV positive donor: report from the first case in the world.
    AIDS 2023.

  12. Koenig LJ, Khurana N, Islam MH, Gopalappa C, et al.
    Closing the gaps in the continuum of depression care for persons with HIV: modeling the impact on viral suppression in the united states.
    AIDS 2023.

  13. Sterman FL, Lalezari JP, Kowalczyk UM, Main DW, et al.
    Bictegravir/Emtricitabine/Tenofovir Alafenamide Plus Doravirine in Highly Treatment-Experienced Men With Multidrug-Resistant HIV.
    AIDS 2023.

  14. Hardiawan D, Juwita MN, Vadra J, Prawiranegara R, et al.
    Cost of improved test and treat strategies in Indonesia: a study of HATI implementation trial.
    AIDS 2023.

  15. Chow DC, Saiki KMW, Siriwardhana C, Lozano-Gerona J, et al.
    Increased transmigration of intermediate monocytes associated with atherosclerotic burden in people with HIV on antiretroviral therapy.
    AIDS 2023.

  16. Lin SH, Khan SM, Zhou W, Brown DW, et al.
    Mosaic chromosomal alterations detected in men living with HIV and the relationship to non-Hodgkin lymphoma.
    AIDS 2023.

  17. Sullivan EV, Zahr NM, Sassoon SA, Pohl KM, et al.
    Postural instability in HIV infection: relation to central and peripheral nervous system markers.
    AIDS 2023.

  18. .
    Effect of antiretroviral therapy care interruptions on mortality in children living with HIV: Erratum.
    AIDS 2023;37:859.

  19. Laurent C, Hentzien M, Pavel S, Didier K, et al.
    Mycobacterium genavense mesenteritis responsible for refractory chylous ascites despite multiple immunomodulatory therapies in a patient with AIDS.
    AIDS 2023;37:856-858.

  20. Von Tokarski F, Fourn E, Faucheron A, Chan Hew Wai A, et al.
    Smallpox vaccine acceptability among French men having sex with men living with HIV in settings of monkeypox outbreak.
    AIDS 2023;37:855-856.

  21. Hu G, Brew BJ.
    Extracellular vesicle small noncoding RNAs: a window into pathogenesis and diagnosis.
    AIDS 2023;37:849-850.

  22. Bernardino JI.
    Estimated glomerular filtration rate equations: one size does not fit all.
    AIDS 2023;37:845-847.

  23. Yamamoto H.
    A contemporary and inflammatory triangle at the mucosa: HIV, antibodies and bacterial STIs.
    AIDS 2023;37:841-843.

  24. Su B, Vanham G.
    Effectiveness of COVID-19 primary and booster vaccination in HIV-infected individuals.
    AIDS 2023;37:837-839.

  25. Cao X, Cao J, Qi H, Yu W, et al.
    Prevalence of primary drug resistance among newly diagnosed HIV-1 infected individuals in Hunan province, China.
    AIDS Res Hum Retroviruses 2023.

  26. Zhang X, Wang Y, An N, Tang X, et al.
    Near-full-length genomic characteristics of three novel HIV-1 CRF01_AE/C recombinant forms among men who have sex with men in Hebei province, China.
    AIDS Res Hum Retroviruses 2023.

  27. Kouamou V, Gundidza P, Ndhlovu CE, Makadzange AT, et al.
    Effects of Gender and Baseline CD4 Count on Post Treatment CD4 Count Recovery and Outcomes in Patients with Advanced HIV Disease: a Retrospective Cohort Study.
    AIDS Res Hum Retroviruses 2023.

  28. You Q, Qiao J, Peng Q, Li W, et al.
    HIV-1 infection promotes cholesterol aggregation by inducing miR-33b-5p to suppress ABCA1 expression.
    AIDS Res Hum Retroviruses 2023.

  29. Li J, Dai M, Song B, Lu H, et al.
    Genetic characteristics of two unique recombinant forms of HIV-1 CRF01_AE/CRF07_BC by near full-length genome from men who have sex with men in Beijing, China.
    AIDS Res Hum Retroviruses 2023.

  30. Cavalcante MG, Gomes PEAC, Parente MSR, Meneses GC, et al.
    Monitoring renal function in HIV patients without kidney disease using endothelial biomarkers: a prospective pilot study.
    AIDS Res Hum Retroviruses 2023.

  31. Mousavi T, Moosazadeh M.
    Association of hospitalization rate, mortality and CD4 T cell count with comorbidity of COVID-19 and HIV: A systematic review and meta-analysis.
    AIDS Res Hum Retroviruses 2023.

  32. Xie L, Li W, Ye WM, Xiao Y, et al.
    Serum ubiquitin C-terminal hydrolase-L1, glial fibrillary acidic protein, and neurofilament light chain are good entry points and biomarker candidates for neurosyphilis diagnosis among patients without HIV to avoid lumbar puncture.
    Clin Infect Dis 2023.

  33. Musumeci S, Najjar I, Boffi El Amari E, Schibler M, et al.
    A case of mpox reinfection.
    Clin Infect Dis 2023.

  34. Filippidis P, Damas J, Viala B, Assal F, et al.
    Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study.
    J Acquir Immune Defic Syndr 2023.

  35. Lee JJ, Barry MP, Kerani RP, Sanchez TH, et al.
    The Pre-Exposure Prophylaxis (PrEP) Care Continuum among English-Speaking Latino Sexual Minority Men in the United States (2014-2020).
    J Acquir Immune Defic Syndr 2023.

  36. Sauceda JA, Dube K, Harris O, Campbell CK, et al.
    The influence of the COVID-19 pandemic on the physical, social, and mental health of Black and Latinx young people with HIV in the United States.
    J Acquir Immune Defic Syndr 2023.

  37. Keene CM, Cassidy T, Zhao Y, Griesel R, et al.
    Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks.
    J Acquir Immune Defic Syndr 2023.

  38. Emery A, Joseph SB, Swanstrom R.
    Nonsuppressible viremia during HIV-1 therapy meets molecular virology.
    J Clin Invest 2023;133.

  39. Joseph SB, Gianella S, Burdo TH, Cinque P, et al.
    Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.
    J Infect Dis 2023;227:S3-S15.

  40. Aung HL, Alagaratnam J, Chan P, Chow FC, et al.
    Cognitive Health in Persons With Human Immunodeficiency Virus: The Impact of Early Treatment, Comorbidities, and Aging.
    J Infect Dis 2023;227:S38-S47.

  41. Mukerji SS, Petersen KJ, Pohl KM, Dastgheyb RM, et al.
    Machine Learning Approaches to Understand Cognitive Phenotypes in People With HIV.
    J Infect Dis 2023;227:S48-S57.

  42. O'Connor EE, Sullivan EV, Chang L, Hammoud DA, et al.
    Imaging of Brain Structural and Functional Effects in People With Human Immunodeficiency Virus.
    J Infect Dis 2023;227:S16-S29.

  43. McIntosh RC, Clark US, Cherner M, Cysique LA, et al.
    The Evolution of Assessing Central Nervous System Complications in Human Immunodeficiency Virus: Where Do We Go From Here?
    J Infect Dis 2023;227:S30-S37.

  44. Rao VR, Brouwers P, Joseph J, Lawhorn C, et al.
    Biotypes of Central Nervous System Complications in People Living With Human Immunodeficiency Virus (HIV): National Institute of Mental Health Perspectives on Advancing the Future of HIV Healthcare.
    J Infect Dis 2023;227:S58-S61.

  45. Rubin LH, Ances BM.
    Moving Toward Disentangling Heterogeneity in Central Nervous System Complications in People With Human Immunodeficiency Virus.
    J Infect Dis 2023;227:S1-S2.

  46. Alkhatib B, Jabari M, Bilasy S, Abdul-Rahman H, et al.
    Resistance to HIV-1 Infection Conferred by a Compound CCR5Delta32 and CCR5 C20S Heterozygote.
    J Infect Dis 2023.

  47. Zhao H, Feng A, Luo D, Wu H, et al.
    Altered gut microbiota is associated with different immunologic responses to antiretroviral therapy in HIV-infected men who have sex with men.
    J Med Virol 2023.

  48. Pisaturo M, Alessio L, Starace M, Macera M, et al.
    J Med Virol 2023.

  49. Madanitsa M, Barsosio HC, Minja DTR, Mtove G, et al.
    Effect of monthly intermittent preventive treatment with dihydroartemisinin-piperaquine with and without azithromycin versus monthly sulfadoxine-pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlle
    Lancet 2023.

  50. Rose PC, De la Rey Nel E, Cotton MF, Otwombe K, et al.
    Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing Regimens.
    Pediatr Infect Dis J 2023.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

27 March 2023

20 March 2023

13 March 2023

06 March 2023

27 February 2023

20 March 2023

Multidisciplinary Journal Club

  1. Sandborn WJ, Vermeire S, Peyrin-Biroulet L, Dubinsky MC, et al.
    Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
    Lancet. 2023 Mar 2:S0140-6736(23)00061-2. doi: 10.1016/S0140-6736(23)00061.

  2. Liu B, Svenningsson P, Ludvigsson JF, Lundholm C, et al.
    beta2-adrenoreceptor agonists, montelukast, and Parkinson's disease risk.
    Ann Neurol. 2023 Mar 10. doi: 10.1002/ana.26638.

  3. Bonnet M, Gabillard D, Domoua S, Muzoora C, et al.
    High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF(R) for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.
    Clin Infect Dis. 2023 Mar 8:ciad125. doi: 10.1093.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016